LONDON, June 14 (Reuters) – In the absence of global standards limiting toxic emissions produced by antibiotics at the point of manufacture, the pharmaceutical industry has come up with its own standard.
The AMR Industry Alliance – a coalition of drugmakers, biotech, diagnostic and other companies involved in the field of antimicrobials – said on Tuesday it was adopting its own standards to ensure the responsible manufacture of antibiotics.